Form D · Pharmaceuticals
QoL meds, LLC
Pittsburgh, PA · CIK 0001470161
Offering snapshot reported Aug 13, 2009 · SEC filing
- Reported sold
- $1.1M Offering amount: $1.1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1.1M Reported outside-investor minimum
- First sale
- Aug 1, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2009 | Initial | $1,100,006 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-133612
Source: Form D, filed Aug 13, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Francois Bitz | Director |
| Larry Bowman | Director |
| Michael Huffer | Director |
| Michael K Mc Mahan | Director |
| Richard Rizzo | Executive |
| David K Robb | Director |
| Daniel Sassano | Director |
| Charles Schellhorn | Director |
| James F Smith | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4900 Perry Highway Building Two
Pittsburgh, PA, 15229
Pittsburgh, PA, 15229